Login
Super Investors 1290 Essex Small Cap Growth Fund

1290 Essex Small Cap Growth Fund

1290 Funds · net assets $116M · 102 holdings as of July 31, 2026. Monthly N-PORT disclosure: the full book, not just equities.

Asset mix

EC: 94.9% · STIV: 4.2% · OTHER: 0.9%

Financial position

Total assets
$119M
Total liabilities
$3.19M
Net assets
$116M
Assets attributable to miscellaneous securities
$0
Assets invested in controlled foreign corporations
$0
Borrowings payable within one year
$0
Payable to controlled companies within one year
$0
Payable to other affiliates within one year
$0
Other liabilities payable within one year
$0
Borrowings payable after one year
$0
Payable to controlled companies after one year
$0
Payable to other affiliates after one year
$0
Other liabilities payable after one year
$0
Payables for delayed-delivery investments
$0
Payables for standby commitments
$0
Liquidation preference of outstanding preferred stock
$0
Cash not reported in Parts C or D
$300K

Monthly flows and gains

Month 1 Month 2 Month 3
Sales $2.62M $2.68M $2.52M
Reinvestment $0 $0 $0
Redemptions $3.18M $2.29M $1.18M
Net realized gain (non-derivative) $3M $-51K $790K
Net unrealized appreciation (non-derivative) $4.6M $7.37M $-12.6M

The three months of the reporting period, as filed; month 3 ends July 31, 2026.

Filing details

Registrant
1290 Funds
Registrant CIK
1605941
Registrant LEI
5493000PXD0IQID6H351
Series
1290 Essex Small Cap Growth Fund
Series ID
S000076802
Series LEI
5493001OKZ2YRG3FGX92
SEC file number
811-22959
Address
1345 Avenue of the Americas, New York, US-NY, 10105, US
Phone
212-554-1234
Form
NPORT-P
Filed
September 25, 2026
Report period ends
October 31, 2026
Report month ends
July 31, 2026
Accession number
000207169126023106
Holding Value % of net assets
Kiniksa Pharmaceuticals International PLC EC $3.03M 2.61%
Lincoln Educational Services Corp. EC $2.94M 2.53%
Leonardo Drs, Inc. EC $2.78M 2.39%
Jpmorgan Prime Money Market Fund STIV $2.67M 2.29%
Adaptive Biotechnologies Corp. EC $2.59M 2.23%
Ceco Environmental Corp. EC $2.42M 2.08%
Invesco Govt And Agcy Lex STIV $2.21M 1.90%
Graham Corp. EC $2.19M 1.88%
Argan, Inc. EC $2.16M 1.86%
Brainsway Ltd. EC $2.11M 1.82%
Arteris, Inc. EC $2.03M 1.74%
Tower Semiconductor Ltd. EC $1.96M 1.69%
Travere Therapeutics, Inc. EC $1.94M 1.67%
Oceaneering International, Inc. EC $1.9M 1.63%
Ouster, Inc. EC $1.68M 1.44%
Liquidia Corp. EC $1.63M 1.40%
Cohu, Inc. EC $1.53M 1.32%
Ligand Pharmaceuticals, Inc. EC $1.53M 1.31%
Lsi Industries, Inc. EC $1.49M 1.28%
Mama's Creations, Inc. EC $1.47M 1.26%
Xeris Biopharma Holdings, Inc. EC $1.41M 1.21%
Tetra Technologies, Inc. EC $1.39M 1.19%
Mirum Pharmaceuticals, Inc. EC $1.36M 1.17%
Nuvation Bio, Inc. EC $1.36M 1.17%
Sterling Infrastructure, Inc. EC $1.34M 1.15%
Columbus Mckinnon Corp. EC $1.3M 1.12%
Kratos Defense & Security Solutions, Inc. EC $1.29M 1.11%
Frequency Electronics, Inc. EC $1.26M 1.08%
Biodesix, Inc. EC $1.25M 1.08%
Willdan Group, Inc. EC $1.25M 1.07%
Xometry, Inc. EC $1.23M 1.06%
Lantronix, Inc. EC $1.21M 1.04%
Werner Enterprises, Inc. EC $1.2M 1.03%
Crexendo, Inc. EC $1.19M 1.02%
Park Aerospace Corp. EC $1.19M 1.02%
Avepoint, Inc. EC $1.18M 1.02%
Gentherm, Inc. EC $1.17M 1.01%
Everus Construction Group, Inc. EC $1.17M 1.01%
Si-bone, Inc. EC $1.17M 1.01%
Semtech Corp. EC $1.16M 1.00%
Hci Group, Inc. EC $1.15M 0.99%
Bluelinx Holdings, Inc. EC $1.14M 0.98%
Precigen, Inc. EC $1.14M 0.98%
Mirion Technologies, Inc. EC $1.14M 0.98%
Apyx Medical Corp. EC $1.13M 0.97%
Red Violet, Inc. EC $1.12M 0.96%
Interface, Inc. EC $1.09M 0.94%
Mitek Systems, Inc. EC $1.08M 0.93%
Johnson Outdoors, Inc. EC $1.07M 0.92%
Amerant Bancorp, Inc. EC $1.07M 0.92%
Orion Group Holdings, Inc. EC $1.05M 0.90%
Daktronics, Inc. EC $1.04M 0.90%
Ambarella, Inc. EC $1.04M 0.89%
Ishares Russell 2000 Growth ETF OTHER $1.02M 0.88%
Realreal, Inc. (the) EC $1.01M 0.87%
Forum Energy Technologies, Inc. EC $1M 0.86%
Diodes, Inc. EC $995K 0.86%
Griffon Corp. EC $994K 0.86%
Liquidity Services, Inc. EC $983K 0.85%
Riskified Ltd. EC $978K 0.84%

Showing top 60 of 102 holdings.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support